• Теги
    • избранные теги
    • Компании765
      • Показать ещё
      • Показать ещё
      Страны / Регионы139
      • Показать ещё
      Международные организации3
      • Показать ещё
Thermo Fisher
27 июля, 20:55

Zimmer (ZBH) Tops Q2 Earnings, Drops View on Dull Sales

Zimmer Biomet's (ZBH) Q2 earnings results disappoint with an unimpressive Knee, Hip and Dental performances.

27 июля, 19:02

Boston Scientific (BSX) Tops Q2 Earnings & Sales, View Up

Boston Scientific's (BSX) Q2 results gain on balanced segmental growth. Currency remains a dampener though.

26 июля, 17:15

Thermo Fisher (TMO) Tops Q2 Earnings & Revenues, View Up

Thermo Fisher Scientific (TMO) continues to gain considerable synergies from FEI Company acquisition. A raised guidance buoys optimism.

26 июля, 14:32

Thermo Fisher (TMO) Beats on Q2 Earnings & Sales Estimates

Thermo Fisher (TMO) rides high in Q2 banking on its analytical instruments segment in particular.

25 июля, 16:59

Quest Diagnostics (DGX) Tops Q2 Earnings, Raises '17 View

Quest Diagnostics (DGX) continues to ride high on its advanced diagnostic offerings. Also, a raised view buoys optimism.

25 июля, 16:32

Medical Instruments' Jul 26 Earnings Lineup: EW, TMO, VAR

The ongoing political conflict resulting in a delay in policy implementation is a major dampener for Q2 earnings in the Medical space.

25 июля, 15:33

Should You Buy Thermo Fisher Scientific Inc. (TMO) Ahead of Earnings?

Thermo Fisher Scientific Inc. (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.

24 июля, 17:29

Can Henry Schein (HSIC) Spring a Surprise in Q2 Earnings?

The timing of Good Friday is likely to dampen sales at Henry Schein (HSIC) in second-quarter 2017. Meanwhile, geographic expansion should continue.

24 июля, 16:25

What's in the Offing for Hologic (HOLX) in Q3 Earnings?

Hologic's (HOLX) gain through product launch and Cynosure integration may get hampered by a dull Cytology performance.

24 июля, 15:39

Can Illumina (ILMN) Spring a Surprise this Earnings Season?

Illumina (ILMN) is well poised to witness steady top-line growth in Q2. Yet, the bottom line may remain stressed.

24 июля, 15:12

What's in the Cards for DaVita (DVA) this Earnings Season?

Despite a stable Kidney Care business, escalating expenses is likely to mar DaVita's (DVA) performance in the second quarter.

21 июля, 16:28

Will Stryker (SYK) Deliver a Beat this Earnings Season?

The growing adoption of Stryker's (SYK) MAKO robots is expected to drive second-quarter 2017 sales in the orthopedic and reconstructive surgery market.

21 июля, 16:21

Is a Surprise in Store for ResMed (RMD) in Q4 Earnings?

Currency headwind is likely to dampen ResMed's (RMD) gains in the COPD and sleep apnea market.

21 июля, 16:16

Boston Scientific (BSX) Q2 Earnings: What Awaits the Stock?

Lower TAVR sales due to recall of Lotus valves within the European and other key markets is likely to mar Boston Scientific's (BSX) top-line performance in Q2.

21 июля, 15:54

McKesson (MCK) Q1 Earnings: Stock Likely to Beat Estimates?

McKesson's (MCK) strategic acquisitions and promising guidance raise optimism for the first quarter of fiscal 2018.

21 июля, 15:26

IDEXX Laboratories (IDXX) Q2 Earnings: A Beat in the Cards?

IDEXX Laboratories' (IDXX) Companion Animal Group business might drive its performance in Q2.

21 июля, 01:02

LabCorp (LH) Q2 Earnings: Is Disappointment in the Cards?

With the Covance Drug Diagnostic arm's revenue and margins projected to decline further, LabCorp???s business in Q2 might face disruption.

20 июля, 16:48

Baxter International (BAX) Q2 Earnings: What's in Store?

Despite an upbeat guidance, lower cyclophosphamide sales are likely to mar Baxter International (BAX) performance in the second quarter 2017.

20 июля, 16:47

Varian Medical (VAR) Q3 Earnings: Is a Surprise in Store?

Varian Medical Systems' (VAR) oncology business strength might drive its performance in Q3.

20 июля, 16:39

Align Technology (ALGN) Q2 Earnings: A Beat in the Cards?

Align Technology (ALGN) might ride high in Q2 banking on growth in the Invisalign space.